{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:19:04Z","timestamp":1794298744962,"version":"4.9.0"},"reference-count":563,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,7]]},"DOI":"10.1093\/eurheartj\/ehaa575","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T07:32:23Z","timestamp":1594366343000},"page":"1289-1367","source":"Crossref","is-referenced-by-count":4134,"title":["2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-5347","authenticated-orcid":false,"given":"Jean-Philippe","family":"Collet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-998X","authenticated-orcid":false,"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barth\u00e9l\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dorobantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Edvardsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Folliguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Jobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterini","family":"Lambrinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil S","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Meliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Sibbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C M","family":"Siontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Chettibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamlet G","family":"Hayrapetyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Najafov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriy I","family":"Stelmashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zumreta","family":"Ku\u0161ljugi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plamen Marinov","family":"Gatzov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosko","family":"Skoric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Panayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Shokry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toomas","family":"Marandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli A","family":"Kajander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Commeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Aladashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Massberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Nikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingibj\u00f6rg J","family":"Gu\u00f0mundsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J","family":"Peace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Beigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazipa","family":"Aidargaliyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shpend","family":"Elezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medet","family":"Beishenkulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aija","family":"Maca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivija","family":"Gustiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Degrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cassar Maempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasko","family":"Kedev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje K","family":"Steigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Legutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Vinereanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Duplyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zavatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Pavlovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Orban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matja\u017e","family":"Bunc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassin Bani","family":"Marjeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faouzi","family":"Addad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eralp","family":"Tutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Parkhomenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Karia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamas A","family":"Mamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Bugiardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Castelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaide","family":"Chieffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Gierlotka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Hermann","family":"Haugaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa A","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A","family":"Katus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Kinnaird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"Kluin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kunadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Lettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Meinila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Mylotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gjin","family":"Ndrepepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmir","family":"Omerovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto F E","family":"Pedretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen E","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sonia","family":"Petronio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pontone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Luciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios J","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Shlyakhto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain A","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sousa-Uva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Vranckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Barth\u00e9l\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dorobantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Edvardsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Folliguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Jobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterini","family":"Lambrinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil S","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Meliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Sibbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C M","family":"Siontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"key":"2026080919270629000_c1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.CIR.102.10.1101","article-title":"Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators","volume":"102","author":"Roe","year":"2000","journal-title":"Circulation"},{"key":"2026080919270629000_c5","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/CIRCULATIONAHA.111.026542","article-title":"Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease","volume":"124","author":"Reynolds","year":"2011","journal-title":"Circulation"},{"key":"2026080919270629000_c6","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","article-title":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury","volume":"137","author":"Chapman","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jacc.2017.07.774","article-title":"Effect of definition on incidence and prognosis of type 2 myocardial infarction","volume":"70","author":"Nestelberger","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c8","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1093\/eurheartj\/ehx457","article-title":"Discrimination of patients with type 2 myocardial infarction","volume":"38","author":"Neumann","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c9","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.113.001258","article-title":"Unstable angina: is it time for a requiem?","volume":"127","author":"Braunwald","year":"2013","journal-title":"Circulation"},{"key":"2026080919270629000_c10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ahj.2012.11.010","article-title":"Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays","volume":"165","author":"Reichlin","year":"2013","journal-title":"Am Heart J"},{"key":"2026080919270629000_c11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","article-title":"High-STEACS investigators. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial","volume":"392","author":"Shah","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/eurheartj\/eht530","article-title":"Biomarkers and acute coronary syndromes: an update","volume":"35","author":"Mueller","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.amjmed.2012.07.015","article-title":"Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis","volume":"125","author":"Reichlin","year":"2012","journal-title":"Am J Med"},{"key":"2026080919270629000_c14","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","article-title":"TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"key":"2026080919270629000_c15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.amjmed.2017.05.037","article-title":"Unstable angina in the era of cardiac troponin assays with improved sensitivity-A clinical dilemma","volume":"130","author":"Eggers","year":"2017","journal-title":"Am J Med"},{"key":"2026080919270629000_c16","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jcin.2018.03.027","article-title":"High-sensitivity cardiac troponin T levels identify patients with non-st-segment elevation acute coronary syndrome who benefit from invasive assessment","volume":"11","author":"Eggers","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c17","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/heartjnl-2018-314305","article-title":"Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarction","volume":"105","author":"Puelacher","year":"2019","journal-title":"Heart"},{"key":"2026080919270629000_c19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.113.004420","article-title":"Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"129","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"2026080919270629000_c20","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1161\/CIRCULATIONAHA.117.030798","article-title":"Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015","volume":"136","author":"Puymirat","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.amjcard.2005.09.073","article-title":"Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative)","volume":"97","author":"Diercks","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c22","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","article-title":"Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004","volume":"27","author":"Mandelzweig","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.annemergmed.2012.07.119","article-title":"Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule","volume":"60","author":"Smith","year":"2012","journal-title":"Ann Emerg Med"},{"key":"2026080919270629000_c24","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/heartjnl-2018-314673","article-title":"Diagnosis of acute myocardial infarction in the presence of left bundle branch block","volume":"105","author":"Nestelberger","year":"2019","journal-title":"Heart"},{"key":"2026080919270629000_c25","first-page":"161","article-title":"Right bundle branch block in patients with suspected myocardial infarction","volume":"8","author":"Neumann","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijcard.2017.01.151","article-title":"Diagnostic and prognostic values of the V-index, a novel ECG marker quantifying spatial heterogeneity of ventricular repolarization, in patients with symptoms suggestive of non-ST-elevation myocardial infarction","volume":"236","author":"Abacherli","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c27","doi-asserted-by":"crossref","first-page":"e12538","DOI":"10.1111\/anec.12538","article-title":"Diagnostic value of the cardiac electrical biomarker, a novel ECG marker indicating myocardial injury, in patients with symptoms suggestive of non-ST-elevation myocardial infarction","volume":"23","author":"Strebel","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026080919270629000_c28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2018.09.040","article-title":"Incremental diagnostic and prognostic value of the QRS-T angle, a 12-lead ECG marker quantifying heterogeneity of depolarization and repolarization, in patients with suspected non-ST-elevation myocardial infarction","volume":"277","author":"Strebel","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c29","first-page":"218","article-title":"Biomarker Study Group of the ESC Acute Cardiovascular Care Association. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies","volume":"6","author":"Mueller","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c30","first-page":"212","article-title":"Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Editor's choice-rule-in of acute myocardial infarction: focus on troponin","volume":"6","author":"Mockel","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c31","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/eurheartj\/ehx492","article-title":"Early diagnosis of acute coronary syndrome","volume":"38","author":"Katus","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c32","first-page":"69","article-title":"Biomarker Study Group of the European Society of Cardiology (ESC) Acute Cardiovascular Care Association (ACCA). How to use D-dimer in acute cardiovascular care","volume":"6","author":"Giannitsis","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c33","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1056\/NEJMoa1803377","article-title":"Application of high-sensitivity troponin in suspected myocardial infarction","volume":"380","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","article-title":"High-sensitivity assays for troponin in patients with cardiac disease","volume":"14","author":"Westermann","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026080919270629000_c35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/CIRCULATIONAHA.117.028901","article-title":"0\/1-hour triage algorithm for myocardial infarction in patients with renal dysfunction","volume":"137","author":"Twerenbold","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c36","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1093\/eurheartj\/ehy514","article-title":"Impact of age on the performance of the ESC 0\/1h-algorithms for early diagnosis of myocardial infarction","volume":"39","author":"Boeddinghaus","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c37","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1373\/clinchem.2019.304725","article-title":"Clinical use of a new high-sensitivity cardiac troponin i assay in patients with suspected myocardial infarction","volume":"65","author":"Boeddinghaus","year":"2019","journal-title":"Clin Chem"},{"key":"2026080919270629000_c38","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/eurheartj\/ehu188","article-title":"Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction","volume":"35","author":"Rubini Gimenez","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c39","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1373\/clinchem.2018.286906","article-title":"Clinical validation of a novel high-sensitivity cardiac troponin i assay for early diagnosis of acute myocardial infarction","volume":"64","author":"Boeddinghaus","year":"2018","journal-title":"Clin Chem"},{"key":"2026080919270629000_c40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1373\/clinchem.2018.300061","article-title":"High-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction","volume":"65","author":"Boeddinghaus","year":"2019","journal-title":"Clin Chem"},{"key":"2026080919270629000_c41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1515\/cclm-2018-1211","article-title":"High sensitivity, contemporary and point-of-care cardiac troponin assays: educational aids developed by the IFCC Committee on Clinical Application of Cardiac Bio-Markers","volume":"57","author":"Collinson","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"2026080919270629000_c42","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamacardio.2018.3368","article-title":"Validity of a novel point-of-care troponin assay for single-test rule-out of acute myocardial infarction","volume":"3","author":"Pickering","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026080919270629000_c43","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1373\/clinchem.2019.307405","article-title":"Diagnostic evaluation of a high-sensitivity troponin I point-of-care assay","volume":"65","author":"Sorensen","year":"2019","journal-title":"Clin Chem"},{"key":"2026080919270629000_c44","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacc.2019.12.065","article-title":"Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I","volume":"75","author":"Boeddinghaus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2018.09.082","article-title":"Cardiac troponin elevation in patients without a specific diagnosis","volume":"73","author":"Eggers","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c46","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.117.028084","article-title":"Direct comparison of cardiac myosin-binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarction","volume":"136","author":"Kaier","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00392-016-1075-9","article-title":"Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin","volume":"106","author":"Boeddinghaus","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2026080919270629000_c48","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1373\/clinchem.2015.242743","article-title":"Optimizing early rule-out strategies for acute myocardial infarction: utility of 1-hour copeptin","volume":"61","author":"Hillinger","year":"2015","journal-title":"Clin Chem"},{"key":"2026080919270629000_c49","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.jacc.2010.01.029","article-title":"Copeptin improves early diagnosis of acute myocardial infarction","volume":"55","author":"Keller","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","article-title":"Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study","volume":"36","author":"Mockel","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c51","first-page":"570","article-title":"Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association. Use of copeptin for rapid rule-out of acute myocardial infarction","volume":"7","author":"Mueller","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2018.10.084","article-title":"Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction","volume":"276","author":"Mueller-Hennessen","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c53","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","article-title":"Incremental value of copeptin for rapid rule out of acute myocardial infarction","volume":"54","author":"Reichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c54","first-page":"407","article-title":"Incremental value of copeptin in suspected acute myocardial infarction very early after symptom onset","volume":"5","author":"Stallone","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijcard.2016.08.304","article-title":"Copeptin for the early rule-out of non-ST-elevation myocardial infarction","volume":"223","author":"Vargas","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2018.11.140","article-title":"Comparison of fourteen rule-out strategies for acute myocardial infarction","volume":"283","author":"Wildi","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.04.133","article-title":"Incremental value of copeptin to highly sensitive cardiac Troponin I for rapid rule-out of myocardial infarction","volume":"190","author":"Wildi","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c58","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2015.04.134","article-title":"Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction","volume":"190","author":"Zellweger","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c59","doi-asserted-by":"crossref","first-page":"E974","DOI":"10.1503\/cmaj.180144","article-title":"Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department","volume":"190","author":"Kavsak","year":"2018","journal-title":"CMAJ"},{"key":"2026080919270629000_c60","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c61","doi-asserted-by":"crossref","first-page":"e0187662","DOI":"10.1371\/journal.pone.0187662","article-title":"Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department","volume":"12","author":"Ambavane","year":"2017","journal-title":"PLoS One"},{"key":"2026080919270629000_c62","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/CIRCULATIONAHA.116.025661","article-title":"Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I","volume":"135","author":"Boeddinghaus","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.annemergmed.2018.11.039","article-title":"A rule-out strategy based on high-sensitivity troponin and HEART score reduces hospital admissions","volume":"73","author":"Ljung","year":"2019","journal-title":"Ann Emerg Med"},{"key":"2026080919270629000_c64","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.jacc.2018.03.515","article-title":"High-sensitivity troponins and outcomes after myocardial infarction","volume":"71","author":"Odqvist","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c65","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1093\/eurheartj\/ehw232","article-title":"Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction","volume":"37","author":"Twerenbold","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c66","first-page":"39","article-title":"RAPID-CPU: a prospective study on implementation of the ESC 0\/1-hour algorithm and safety of discharge after rule-out of myocardial infarction","volume":"9","author":"Stoyanov","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.annemergmed.2015.11.013","article-title":"Multicenter evaluation of a 0-hour\/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T","volume":"68","author":"Mueller","year":"2016","journal-title":"Ann Emerg Med"},{"key":"2026080919270629000_c68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamacardio.2016.0695","article-title":"Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm","volume":"1","author":"Neumann","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026080919270629000_c69","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2018.05.040","article-title":"Prospective validation of the 0\/1-h algorithm for early diagnosis of myocardial infarction","volume":"72","author":"Twerenbold","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ahj.2016.07.013","article-title":"Safety and efficacy of the 0 h\/3 h protocol for rapid rule out of myocardial infarction","volume":"181","author":"Wildi","year":"2016","journal-title":"Am Heart J"},{"key":"2026080919270629000_c71","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/CIRCULATIONAHA.118.034260","article-title":"Direct comparison of the 0\/1h and 0\/3h algorithms for early rule-out of acute myocardial infarction","volume":"137","author":"Badertscher","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c72","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCULATIONAHA.116.025021","article-title":"Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction","volume":"135","author":"Chapman","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c73","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/heartjnl-2018-314306","article-title":"Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome","volume":"105","author":"Chapman","year":"2019","journal-title":"Heart"},{"key":"2026080919270629000_c74","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.119.042891","article-title":"A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT)","volume":"140","author":"Chew","year":"2019","journal-title":"Circulation"},{"key":"2026080919270629000_c75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCULATIONAHA.111.023937","article-title":"Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction","volume":"124","author":"Reichlin","year":"2011","journal-title":"Circulation"},{"key":"2026080919270629000_c76","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archinternmed.2012.3698","article-title":"One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T","volume":"172","author":"Reichlin","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026080919270629000_c77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2018.12.001","article-title":"Evaluation of a new ultra-sensitivity troponin I assay in patients with suspected myocardial infarction","volume":"283","author":"Neumann","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c78","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1373\/clinchem.2015.249508","article-title":"Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction by use of high-sensitivity cardiac troponin I","volume":"62","author":"Boeddinghaus","year":"2016","journal-title":"Clin Chem"},{"key":"2026080919270629000_c79","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.2017.17488","article-title":"Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome","volume":"318","author":"Chapman","year":"2017","journal-title":"JAMA"},{"key":"2026080919270629000_c80","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1373\/clinchem.2017.283887","article-title":"Evaluating rapid rule-out of acute myocardial infarction using a high-sensitivity cardiac troponin I assay at presentation","volume":"64","author":"Greenslade","year":"2018","journal-title":"Clin Chem"},{"key":"2026080919270629000_c81","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M16-2562","article-title":"Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis","volume":"166","author":"Pickering","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026080919270629000_c82","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(15)00391-8","article-title":"High-STEACS investigators. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study","volume":"386","author":"Shah","year":"2015","journal-title":"Lancet"},{"key":"2026080919270629000_c83","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1373\/clinchem.2016.268359","article-title":"Direct comparison of 2 rule-out strategies for acute myocardial infarction: 2-h accelerated diagnostic protocol vs 2-h algorithm","volume":"63","author":"Wildi","year":"2017","journal-title":"Clin Chem"},{"key":"2026080919270629000_c84","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1373\/clinchem.2019.305193","article-title":"Two-hour algorithm for rapid triage of suspected acute myocardial infarction using a high-sensitivity cardiac troponin I assay","volume":"65","author":"Nestelberger","year":"2019","journal-title":"Clin Chem"},{"key":"2026080919270629000_c85","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijcard.2016.01.112","article-title":"Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h\/1h-algorithm for the early diagnosis of acute myocardial infarction","volume":"207","author":"Nestelberger","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c86","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1373\/clinchem.2011.171496","article-title":"Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction","volume":"58","author":"Hammarsten","year":"2012","journal-title":"Clin Chem"},{"key":"2026080919270629000_c87","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.otsr.2009.10.013","article-title":"EOS orthopaedic imaging system to study patellofemoral kinematics: assessment of uncertainty","volume":"96","author":"Azmy","year":"2010","journal-title":"Orthop Traumatol Surg Res"},{"key":"2026080919270629000_c88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00392-016-1020-y","article-title":"Gender-specific uncertainties in the diagnosis of acute coronary syndrome","volume":"106","author":"Hillinger","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2026080919270629000_c89","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.117.030320","article-title":"High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome","volume":"137","author":"Miller-Hodges","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c90","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCULATIONAHA.117.031940","article-title":"Impact of the US food and drug administration-approved sex-specific cutoff values for high-sensitivity cardiac troponin T to diagnose myocardial infarction","volume":"137","author":"Rubini Gimenez","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c91","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamacardio.2016.2882","article-title":"Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction","volume":"1","author":"Rubini Gimenez","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026080919270629000_c92","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijcard.2016.01.213","article-title":"Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T - sub-analysis from the TRAPID-AMI study","volume":"209","author":"Mueller-Hennessen","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c93","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007297","article-title":"Relations of sex to \u00a0diagnosis and outcomes in acute coronary syndrome","volume":"7","author":"Sorensen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026080919270629000_c94","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.echo.2014.01.019","article-title":"Early assessment of strain echocardiography can accurately exclude significant coronary artery stenosis in suspected non-ST-segment elevation acute coronary syndrome","volume":"27","author":"Dahlslett","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080919270629000_c95","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/hrt.2009.188391","article-title":"Acute coronary occlusion in non-ST-elevation acute coronary syndrome: outcome and early identification by strain echocardiography","volume":"96","author":"Grenne","year":"2010","journal-title":"Heart"},{"key":"2026080919270629000_c96","first-page":"3","article-title":"The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association","volume":"4","author":"Lancellotti","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c97","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrcardio.2017.56","article-title":"Acute Heart Failure Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Expert consensus document: echocardiography and lung ultrasonography for the assessment and management of acute heart failure","volume":"14","author":"Price","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026080919270629000_c98","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/eurheartj\/ehy669","article-title":"Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging","volume":"40","author":"Fox","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/CIRCIMAGING.112.980797","article-title":"Incremental diagnostic and prognostic value of contemporary stress echocardiography in a chest pain unit: mortality and morbidity outcomes from a real-world setting","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080919270629000_c100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurheartj\/ehn492","article-title":"European Association of Echocardiography. Stress Echocardiography Expert Consensus Statement\u2013Executive Summary: European Association of Echocardiography (EAE a registered branch of the ESC)","volume":"30","author":"Sicari","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c101","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.amjcard.2010.08.066","article-title":"Usefulness of contrast stress-echocardiography or exercise-electrocardiography to predict long-term acute coronary syndromes in patients presenting with chest pain without electrocardiographic abnormalities or 12-hour troponin elevation","volume":"107","author":"Gaibazzi","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c102","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/ehjci\/jex182","article-title":"Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017","volume":"18","author":"Senior","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919270629000_c103","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jacc.2013.04.082","article-title":"Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study","volume":"62","author":"Senior","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c104","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2005.11.059","article-title":"Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain","volume":"47","author":"Ingkanisorn","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c105","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.jacc.2019.09.027","article-title":"Initial imaging-guided strategy versus routine care in patients with non-st-segment elevation myocardial infarction","volume":"74","author":"Smulders","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c106","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12350-013-9736-9","article-title":"Stress myocardial perfusion imaging for the evaluation and triage of chest pain in the emergency department: a randomized controlled trial","volume":"20","author":"Lim","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"2026080919270629000_c107","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2967\/jnumed.115.166595","article-title":"Optimizing evaluation of patients with low-to-intermediate-risk acute chest pain: a randomized study comparing stress myocardial perfusion tomography incorporating stress-only imaging versus cardiac CT","volume":"57","author":"Nabi","year":"2016","journal-title":"J Nucl Med"},{"key":"2026080919270629000_c108","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12350-012-9520-2","article-title":"A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department","volume":"19","author":"Samad","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"2026080919270629000_c109","doi-asserted-by":"crossref","first-page":"k504","DOI":"10.1136\/bmj.k504","article-title":"Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials","volume":"360","author":"Siontis","year":"2018","journal-title":"BMJ"},{"key":"2026080919270629000_c110","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jacc.2011.03.068","article-title":"The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial","volume":"58","author":"Goldstein","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c111","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jacc.2006.08.064","article-title":"A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain","volume":"49","author":"Goldstein","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c112","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa1201161","article-title":"ROMICAT-II Investigators. Coronary CT angiography versus standard evaluation in acute chest pain","volume":"367","author":"Hoffmann","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c113","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1201163","article-title":"CT angiography for safe discharge of patients with possible acute coronary syndromes","volume":"366","author":"Litt","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c114","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacc.2012.11.061","article-title":"Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials","volume":"61","author":"Hulten","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2015.10.045","article-title":"Coronary CT angiography for suspected ACS in the era of high-sensitivity troponins: randomized multicenter study","volume":"67","author":"Dedic","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c116","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacc.2019.12.012","article-title":"Coronary CT angiography in patients with non-st-segment elevation acute coronary syndrome","volume":"75","author":"Linde","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c117","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/eurheartj\/ehy077","article-title":"International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c118","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.106.641936","article-title":"Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes","volume":"114","author":"O'Donoghue","year":"2006","journal-title":"Circulation"},{"key":"2026080919270629000_c119","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/eurheartj\/eht218","article-title":"Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays","volume":"35","author":"Haaf","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c120","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/ehs154","article-title":"Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c121","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/eurheartj\/ehq509","article-title":"Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c122","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCULATIONAHA.118.033631","article-title":"B-type natriuretic peptide assessment in patients undergoing revascularization for left main coronary artery disease","volume":"138","author":"Redfors","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c123","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/eurheartj\/ehz572","article-title":"Quantifying heart failure using natriuretic peptides may help the HEART team in decision-making","volume":"40","author":"Michou","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c124","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1093\/eurheartj\/ehz394","article-title":"Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease","volume":"40","author":"Zhang","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c125","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"de Lemos","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c126","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0735-1097(03)00168-2","article-title":"Evaluation of B-type natriuretic peptide for risk assessment in unstable angina\/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18","volume":"41","author":"Morrow","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c127","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ahj.2013.03.014","article-title":"Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men","volume":"166","author":"Balmelli","year":"2013","journal-title":"Am Heart J"},{"key":"2026080919270629000_c128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jacc.2010.01.060","article-title":"Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study","volume":"56","author":"Dhillon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2013.04.011","article-title":"Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction)","volume":"62","author":"Maisel","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c130","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide","volume":"105","author":"Sabatine","year":"2002","journal-title":"Circulation"},{"key":"2026080919270629000_c131","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.acvd.2015.04.002","article-title":"Copeptin in acute coronary syndromes and heart failure management: state of the art and future directions","volume":"108","author":"Schurtz","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"2026080919270629000_c132","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation"},{"key":"2026080919270629000_c133","doi-asserted-by":"crossref","first-page":"e7947","DOI":"10.1371\/journal.pone.0007947","article-title":"Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores","volume":"4","author":"Aragam","year":"2009","journal-title":"PLoS One"},{"key":"2026080919270629000_c134","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cct.2012.01.001","article-title":"TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients","volume":"33","author":"D'Ascenzo","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"2026080919270629000_c135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/hrt.2008.144022","article-title":"Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database","volume":"95","author":"Gale","year":"2009","journal-title":"Heart"},{"key":"2026080919270629000_c136","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"2026080919270629000_c137","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"2026080919270629000_c138","doi-asserted-by":"crossref","first-page":"e004425","DOI":"10.1136\/bmjopen-2013-004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score","volume":"4","author":"Fox","year":"2014","journal-title":"BMJ Open"},{"key":"2026080919270629000_c139","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"2026080919270629000_c140","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/hrt.2009.190827","article-title":"The Global Registry of Acute Coronary Events, 1999 to 2009\u2013GRACE","volume":"96","author":"Fox","year":"2010","journal-title":"Heart"},{"key":"2026080919270629000_c141","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/ehjqcco\/qcy002","article-title":"Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry","volume":"4","author":"Bing","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026080919270629000_c142","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/CIRCOUTCOMES.111.000072","article-title":"Perceived Risk of Ischemic and Bleeding Events in Acute Coronary Syndrome Patients (PREDICT) Study Investigators. Perceived risk of ischemic and bleeding events in acute coronary syndromes","volume":"6","author":"Chew","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080919270629000_c143","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1093\/eurheartj\/ehy517","article-title":"Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction","volume":"39","author":"Hall","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c144","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/hrt.2005.084830","article-title":"Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE)","volume":"93","author":"Fox","year":"2007","journal-title":"Heart"},{"key":"2026080919270629000_c145","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijcard.2018.08.015","article-title":"The risk-treatment paradox in non-ST-elevation myocardial infarction patients according to their estimated GRACE risk","volume":"272","author":"Saar","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c146","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ahj.2015.07.032","article-title":"A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS)","volume":"170","author":"Chew","year":"2015","journal-title":"Am Heart J"},{"key":"2026080919270629000_c147","doi-asserted-by":"crossref","first-page":"e032165","DOI":"10.1136\/bmjopen-2019-032165","article-title":"Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial","volume":"9","author":"Everett","year":"2019","journal-title":"BMJ Open"},{"key":"2026080919270629000_c148","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2016.10766","article-title":"Association of clinical factors and therapeutic strategies with improvements in survival following non-st-elevation myocardial infarction, 2003-2013","volume":"316","author":"Hall","year":"2016","journal-title":"JAMA"},{"key":"2026080919270629000_c149","doi-asserted-by":"crossref","first-page":"e005355","DOI":"10.1161\/CIRCOUTCOMES.118.005355","article-title":"Causes of mortality after percutaneous coronary intervention","volume":"12","author":"Bricker","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080919270629000_c150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2003.05.004","article-title":"GUSTO-IIb and PURSUIT Investigators. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT","volume":"148","author":"Chang","year":"2004","journal-title":"Am Heart J"},{"key":"2026080919270629000_c151","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ncpcardio1302","article-title":"Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry","volume":"5","author":"Fox","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2026080919270629000_c152","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.113.006518","article-title":"Trends in cause of death after percutaneous coronary intervention","volume":"129","author":"Spoon","year":"2014","journal-title":"Circulation"},{"key":"2026080919270629000_c153","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"DAPT Study Investigators. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"2026080919270629000_c154","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"PRECISE-DAPT Study Investigators. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"2026080919270629000_c155","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) bleeding score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"2026080919270629000_c156","first-page":"222","article-title":"Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome","volume":"1","author":"Abu-Assi","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c157","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c158","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c159","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","volume":"65","author":"Valgimigli","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c161","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","article-title":"SENIOR investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial","volume":"391","author":"Varenne","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c162","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c163","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2017.01.010","article-title":"Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes","volume":"186","author":"Ducrocq","year":"2017","journal-title":"Am Heart J"},{"key":"2026080919270629000_c164","first-page":"804","article-title":"Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial","volume":"38","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2019.11.132","article-title":"Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor","volume":"301","author":"Bianco","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c166","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/M16-2389","article-title":"Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention","volume":"167","author":"Piccolo","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026080919270629000_c167","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point","volume":"51","author":"Ndrepepa","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c168","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c169","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c171","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c172","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","article-title":"Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention","volume":"36","author":"Aradi","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c173","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/eurheartj\/eht375","article-title":"Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention","volume":"35","author":"Aradi","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c174","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"ISAR-REACT 5 Trial Investigators. Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Schupke","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c175","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz917","article-title":"Effects of clopidogrel vs. prasugrel vs. ticagrelor \u00a0on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study","author":"Schnorbus","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c176","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehv717","article-title":"Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?","volume":"37","author":"Sibbing","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c177","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes","volume":"369","author":"Montalescot","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c178"},{"key":"2026080919270629000_c179","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/eurheartj\/ehr373","article-title":"Antiplatelet agents for the treatment and prevention of atherothrombosis","volume":"32","author":"Patrono","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"2026080919270629000_c181","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"2026080919270629000_c182","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"2026080919270629000_c183","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2010.1320","article-title":"Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA\/OASIS-8 randomized trial","volume":"304","author":"Steg","year":"2010","journal-title":"JAMA"},{"key":"2026080919270629000_c184","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data","volume":"382","author":"Steg","year":"2013","journal-title":"Lancet"},{"key":"2026080919270629000_c185","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c186","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c187","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c188","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c189","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c190","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"2026080919270629000_c191","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehn169","article-title":"PRAGUE-8 Trial Investigators. Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8","volume":"29","author":"Widimsky","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c192","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"2026080919270629000_c193","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"key":"2026080919270629000_c194","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1136\/bmj.e553","article-title":"Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis","volume":"344","author":"Silvain","year":"2012","journal-title":"BMJ"},{"key":"2026080919270629000_c195","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.100.15.1602","article-title":"Assessment of the treatment effect of enoxaparin for unstable angina\/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"2026080919270629000_c196","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"2026080919270629000_c197","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1507854","article-title":"Bivalirudin or unfractionated heparin in acute coronary syndromes","volume":"373","author":"Valgimigli","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c198","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","article-title":"ISAR-REACT 4 Trial Investigators. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction","volume":"365","author":"Kastrati","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c199","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jacc.2006.05.058","article-title":"SYNERGY Trial Investigators. A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes","volume":"48","author":"Cohen","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(14)61216-2","article-title":"Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials","volume":"384","author":"Cavender","year":"2014","journal-title":"Lancet"},{"key":"2026080919270629000_c201","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4244\/EIJY14M08_01","article-title":"Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials","volume":"11","author":"Cassese","year":"2015","journal-title":"EuroIntervention"},{"key":"2026080919270629000_c202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2016.01.206","article-title":"Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"209","author":"Zhang","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c203","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00392-018-1251-1","article-title":"Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials","volume":"107","author":"Nuhrenberg","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2026080919270629000_c204","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa1706443","article-title":"Bivalirudin versus heparin monotherapy in myocardial infarction","volume":"377","author":"Erlinge","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c206","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c207","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"2026080919270629000_c208","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(18)30493-8","article-title":"SMART-DATE investigators. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial","volume":"391","author":"Hahn","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c209","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"key":"2026080919270629000_c210","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c211","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c212","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c213","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/eurheartj\/ehv531","article-title":"Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54","volume":"37","author":"Bonaca","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c214","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c215","first-page":"1309","article-title":"THEMIS Steering Committee and Investigators","volume":"381","author":"Steg","year":"2019","journal-title":"Ticagrelor in patients with stable coronary disease and diabetes. N Engl J Med"},{"key":"2026080919270629000_c216","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2016.10.006","article-title":"Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study","volume":"183","author":"Zettler","year":"2017","journal-title":"Am Heart J"},{"key":"2026080919270629000_c217","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.117.031164","article-title":"International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies","volume":"136","author":"Angiolillo","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c218","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","article-title":"Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study","volume":"38","author":"Cuisset","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c219","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4244\/EIJ-D-17-00092","article-title":"Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry","volume":"13","author":"De Luca","year":"2017","journal-title":"EuroIntervention"},{"key":"2026080919270629000_c220","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","article-title":"Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial","volume":"390","author":"Sibbing","year":"2017","journal-title":"Lancet"},{"key":"2026080919270629000_c221","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","article-title":"A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI","volume":"381","author":"Claassens","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c222","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","article-title":"Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention","volume":"12","author":"Sibbing","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c223","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","article-title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c224","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"ATLAS ACS 2\u2013TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c225","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c226","first-page":"1034","article-title":"Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients","volume":"38","author":"Palmerini","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c227","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c228","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"2026080919270629000_c229","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.jacc.2019.08.1002","article-title":"ACTION Study Group. Long-term evolution of premature coronary artery disease","volume":"74","author":"Collet","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c230","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.jacc.2019.04.046","article-title":"Association of multiple enrichment criteria with ischemic and bleeding risks among COMPASS-eligible patients","volume":"73","author":"Darmon","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c231","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c232","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.amjcard.2009.03.053","article-title":"Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO])","volume":"104","author":"Gilard","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c233","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","article-title":"Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c234","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis","volume":"51","author":"Ruiz-Nodar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c235","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/eurheartj\/eht557","article-title":"Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry","volume":"35","author":"Beyer-Westendorf","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c236","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4244\/EIJY14M06_07","article-title":"Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial","volume":"11","author":"Dewilde","year":"2015","journal-title":"EuroIntervention"},{"key":"2026080919270629000_c237","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjcard.2012.02.045","article-title":"Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention","volume":"110","author":"Kiviniemi","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c238","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"RE-DUAL PCI Steering Committee and Investigators. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c239","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"2026080919270629000_c240","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c241","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or pci in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c242","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"2026080919270629000_c243","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2019.1880","article-title":"Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials","volume":"4","author":"Lopes","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026080919270629000_c244","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/eurheartj\/ehz732","article-title":"Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials","volume":"40","author":"Gargiulo","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c245","first-page":"192","article-title":"2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS),","volume":"21","author":"Lip","year":"2019","journal-title":"Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace"},{"key":"2026080919270629000_c246","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c247","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/CIRCULATIONAHA.119.043308","article-title":"Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention: insights from the AUGUSTUS trial","volume":"140","author":"Windecker","year":"2019","journal-title":"Circulation"},{"key":"2026080919270629000_c248","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"key":"2026080919270629000_c249","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2013.05.029","article-title":"Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention","volume":"62","author":"Lamberts","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c250","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c251","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ahj.2017.10.009","article-title":"Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: rationale and design of the ENTRUST-AF PCI trial","volume":"196","author":"Vranckx","year":"2018","journal-title":"Am Heart J"},{"key":"2026080919270629000_c252","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejcts.2008.02.024","article-title":"Guideline on antiplatelet and anticoagulation management in cardiac surgery","volume":"34","author":"Dunning","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026080919270629000_c253","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.acvd.2011.09.001","article-title":"Working Group on Perioperative Haemostasis, French Study Group on Thrombosis and Haemostasis. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis","volume":"104","author":"Sie","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"2026080919270629000_c254","first-page":"1710","article-title":"Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis","volume":"38","author":"Niessner","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c255","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c256","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c257","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c258","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c259","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c260","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"2026080919270629000_c261","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c262","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH15-07-0565","article-title":"Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy","volume":"114","author":"Lip","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026080919270629000_c263","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/STROKEAHA.115.012609","article-title":"Stroke Outcomes Research Working Group. Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc score of 1: systematic review and meta-analysis","volume":"47","author":"Joundi","year":"2016","journal-title":"Stroke"},{"key":"2026080919270629000_c264","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c265","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c266","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.300.1.71","article-title":"Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis","volume":"300","author":"O'Donoghue","year":"2008","journal-title":"JAMA"},{"key":"2026080919270629000_c267","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1001\/jama.293.23.2908","article-title":"Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"2026080919270629000_c268","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c269","first-page":"CD004815","article-title":"Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era","author":"Fanning","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919270629000_c270","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjcard.2016.11.005","article-title":"Meta-analysis of randomized trials of long-term all-cause mortality in patients with non-ST-elevation acute coronary syndrome managed with routine invasive versus selective invasive strategies","volume":"119","author":"Elgendy","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c271","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c272","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/CIRCULATIONAHA.118.037152","article-title":"Early versus standard care invasive examination and treatment of patients with non-ST-segment elevation acute coronary syndrome","volume":"138","author":"Kofoed","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c273","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/eurheartj\/ehy651","article-title":"Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial","volume":"40","author":"Lemkes","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c274","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-158-4-201302190-00006","article-title":"Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis","volume":"158","author":"Navarese","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026080919270629000_c275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2015.04.808","article-title":"Timing of invasive strategy in NSTE-ACS patients and effect on clinical outcomes: a systematic review and meta-analysis of randomized controlled trials","volume":"241","author":"Milasinovic","year":"2015","journal-title":"Atherosclerosis"},{"key":"2026080919270629000_c276","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/ehq276","article-title":"Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes","volume":"32","author":"Katritsis","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c277","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(17)31490-3","article-title":"Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials","volume":"390","author":"Jobs","year":"2017","journal-title":"Lancet"},{"key":"2026080919270629000_c278","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jcin.2016.09.017","article-title":"Timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes and clinical outcomes: an updated meta-analysis","volume":"9","author":"Bonello","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c279","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijcard.2014.12.089","article-title":"Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The Sisca randomized trial","volume":"182","author":"Reuter","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c280","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/clc.20785","article-title":"Comparison of immediate vs early invasive strategy in patients with first acute non-ST-elevation myocardial infarction","volume":"33","author":"Sciahbasi","year":"2010","journal-title":"Clin Cardiol"},{"key":"2026080919270629000_c281","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jcin.2015.11.018","article-title":"Immediate versus delayed invasive intervention for Non-STEMI patients: the RIDDLE-NSTEMI study","volume":"9","author":"Milosevic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c282","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/eurheartj\/ehr418","article-title":"Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI trial)","volume":"33","author":"Thiele","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c283","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.290.12.1593","article-title":"Evaluation of prolonged antithrombotic pretreatment (\"cooling-off\" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial","volume":"290","author":"Neumann","year":"2003","journal-title":"JAMA"},{"key":"2026080919270629000_c284","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4244\/EIJV9I1A9","article-title":"Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial","volume":"9","author":"Badings","year":"2013","journal-title":"EuroIntervention"},{"key":"2026080919270629000_c285","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0195-668X(03)00259-8","article-title":"A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b\/3a upstream therapy and acute coronary syndromes","volume":"24","author":"van 't Hof","year":"2003","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c286","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jcin.2020.01.231","article-title":"Optimal timing of intervention in NSTE-ACS without pre-treatment: the EARLY randomized trial","volume":"13","author":"Lemesle","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c287","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2009.1267","article-title":"Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial","volume":"302","author":"Montalescot","year":"2009","journal-title":"JAMA"},{"key":"2026080919270629000_c288","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2016.05.034","article-title":"Contemporary review on spontaneous coronary artery dissection","volume":"68","author":"Saw","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c289","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/hrt.2008.162073","article-title":"Spontaneous coronary artery dissection","volume":"96","author":"Vrints","year":"2010","journal-title":"Heart"},{"key":"2026080919270629000_c290","first-page":"710","article-title":"Spontaneous coronary artery dissection: a Western Denmark Heart Registry study","volume":"74","author":"Mortensen","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026080919270629000_c291","first-page":"263","article-title":"Prevalence of spontaneous coronary artery dissection in patients with acute coronary syndrome","volume":"5","author":"Nishiguchi","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c292","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/eurheartj\/ehy080","article-title":"European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection","volume":"39","author":"Adlam","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c293","first-page":"609","article-title":"Spontaneous coronary artery dissection: challenges of coronary computed tomography angiography","volume":"7","author":"Eleid","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c294","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2011.08.082","article-title":"Diagnosis of spontaneous coronary artery dissection by optical coherence tomography","volume":"59","author":"Alfonso","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c295","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcin.2017.08.016","article-title":"Trends of incidence, clinical presentation, and in-hospital mortality among women with acute myocardial infarction with or without spontaneous coronary artery dissection: a population-based analysis","volume":"11","author":"Mahmoud","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c296","first-page":"614","article-title":"Medical treatment or revascularisation as the best approach for spontaneous coronary artery dissection: a systematic review and meta-analysis","volume":"7","author":"Martins","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c297","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcin.2018.12.011","article-title":"Natural history of spontaneous coronary artery dissection with spontaneous angiographic healing","volume":"12","author":"Hassan","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c298","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jacc.2017.06.053","article-title":"Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence","volume":"70","author":"Saw","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c299","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2014.07.987","article-title":"Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction","volume":"64","author":"Cuculi","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c300","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/eurheartj\/ehs436","article-title":"Functional assessment of coronary stenoses: can we live without it?","volume":"34","author":"Pijls","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c301","doi-asserted-by":"crossref","first-page":"e002207","DOI":"10.1161\/CIRCINTERVENTIONS.114.002207","article-title":"Assessment of Fractional Flow Reserve in Patients With Recent Non-ST-Segment-Elevation Myocardial Infarction: Comparative Study With 3-T Stress Perfusion Cardiac Magnetic Resonance Imaging","volume":"8","author":"Layland","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080919270629000_c302","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcin.2010.08.025","article-title":"Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction","volume":"3","author":"Ntalianis","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c303","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.jacc.2006.01.065","article-title":"Fractional flow reserve of infarct-related arteries identifies reversible defects on noninvasive myocardial perfusion imaging early after myocardial infarction","volume":"47","author":"Samady","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c304","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jcin.2011.08.008","article-title":"Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study","volume":"4","author":"Sels","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c305","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcin.2018.05.029","article-title":"Safety of the deferral of coronary revascularization on the basis of instantaneous wave-free ratio and fractional flow reserve measurements in stable coronary artery disease and acute coronary syndromes","volume":"11","author":"Escaned","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c306","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacc.2016.06.035","article-title":"Long-term prognosis of deferred acute coronary syndrome lesions based on nonischemic fractional flow reserve","volume":"68","author":"Hakeem","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c307","doi-asserted-by":"crossref","first-page":"e1112","DOI":"10.4244\/EIJ-D-17-00110","article-title":"Prognosis of deferred non-culprit lesions according to fractional flow reserve in patients with acute coronary syndrome","volume":"13","author":"Lee","year":"2017","journal-title":"EuroIntervention"},{"key":"2026080919270629000_c308","doi-asserted-by":"crossref","first-page":"e002172","DOI":"10.1161\/JAHA.115.002172","article-title":"Association of lower fractional flow reserve values with higher risk of adverse cardiac events for lesions deferred revascularization among patients with acute coronary syndrome","volume":"4","author":"Masrani Mehta","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2026080919270629000_c309","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehu338","article-title":"Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial","volume":"36","author":"Layland","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c310","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"Gotberg","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c311","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c312","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/eurheartj\/ehz332","article-title":"Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions","volume":"40","author":"Johnson","year":"2019","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c313","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.jacc.2018.09.013","article-title":"Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial","volume":"72","author":"Zhang","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c314","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/S0140-6736(16)31922-5","article-title":"Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial","volume":"388","author":"Ali","year":"2016","journal-title":"Lancet"},{"key":"2026080919270629000_c315","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.116.024393","article-title":"Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (Does Optical Coherence Tomography Optimize Results of Stenting)","volume":"134","author":"Meneveau","year":"2016","journal-title":"Circulation"},{"key":"2026080919270629000_c316","first-page":"441","article-title":"Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: the EYESHOT Study","volume":"4","author":"De Luca","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c317","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/2012.jama.11348","article-title":"Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction","volume":"308","author":"Puymirat","year":"2012","journal-title":"JAMA"},{"key":"2026080919270629000_c318","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jcin.2012.05.008","article-title":"Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome)","volume":"5","author":"Puymirat","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c319","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2019.06.068","article-title":"In-hospital coronary revascularization rates and post-discharge mortality risk in non-ST-segment elevation acute coronary syndrome","volume":"74","author":"Bueno","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c320","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.166.18.2027","article-title":"Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative","volume":"166","author":"Mehta","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026080919270629000_c321","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c322","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijcard.2016.06.089","article-title":"BLITZ 4 Investigators. Invasive strategy in non-ST-segment elevation acute coronary syndrome: what should be the benchmark target in the real world patients? Insights from BLITZ-4 Quality Campaign","volume":"220","author":"Olivari","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c323","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmj.38335.390718.82","article-title":"Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study","volume":"330","author":"Van de Werf","year":"2005","journal-title":"BMJ"},{"key":"2026080919270629000_c324","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ehjcvp\/pvv017","article-title":"Medical management: the dark side of acute coronary syndromes","volume":"1","author":"Bueno","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026080919270629000_c325","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehu160","article-title":"Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial","volume":"35","author":"Lindholm","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c326","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/clc.22425","article-title":"Effects of ranolazine in patients with chronic angina in patients with and without percutaneous coronary intervention for acute coronary syndrome: observations from the MERLIN-TIMI 36 trial","volume":"38","author":"Gutierrez","year":"2015","journal-title":"Clin Cardiol"},{"key":"2026080919270629000_c327","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacc.2016.10.009","article-title":"2-year outcomes of high bleeding risk patients after polymer-free drug-coated stents","volume":"69","author":"Garot","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c328","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c329","first-page":"10","article-title":"Thrombus aspiration in non-ST-elevation myocardial infarction - 12-month clinical outcome of the randomised TATORT-NSTEMI trial","volume":"6","author":"Meyer-Saraei","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c330","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2014.05.064","article-title":"Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial","volume":"64","author":"Thiele","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c331","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jacc.2008.12.073","article-title":"Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice","volume":"53","author":"Doyle","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c332","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001645","article-title":"\u00a0Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis","volume":"8","author":"Kwok","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080919270629000_c333","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCINTERVENTIONS.113.000433","article-title":"Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention","volume":"6","author":"Ndrepepa","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080919270629000_c334","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.jacc.2010.01.039","article-title":"The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions","volume":"55","author":"Rao","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c335","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","article-title":"RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial","volume":"377","author":"Jolly","year":"2011","journal-title":"Lancet"},{"key":"2026080919270629000_c336","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(18)31714-8","article-title":"Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial","volume":"392","author":"Valgimigli","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c337","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcin.2016.04.014","article-title":"Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials","volume":"9","author":"Ferrante","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c338","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)\u2013Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c339","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/hrt.2005.060541","article-title":"Randomised Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial","volume":"92","author":"Poole-Wilson","year":"2006","journal-title":"Heart"},{"key":"2026080919270629000_c340","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(16)31276-4","article-title":"FRISC-II study group. Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study","volume":"388","author":"Wallentin","year":"2016","journal-title":"Lancet"},{"key":"2026080919270629000_c341","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jacc.2018.07.089","article-title":"Complete versus culprit-only lesion intervention in patients with acute coronary syndromes","volume":"72","author":"Rathod","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c342","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstrom","year":"2015","journal-title":"Lancet"},{"key":"2026080919270629000_c343","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Compare-Acute Investigators. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c344","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"COMPLETE Trial Steering Committee and Investigators. Complete revascularization with multivessel PCI for myocardial infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c345","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jacc.2015.10.082","article-title":"Single-staged compared with multi-staged PCI in multivessel NSTEMI patients: the SMILE trial","volume":"67","author":"Sardella","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c346","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","article-title":"One-year outcomes after PCI strategies in cardiogenic shock","volume":"379","author":"Thiele","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c347","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.amjcard.2011.04.005","article-title":"Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007","volume":"108","author":"Ranasinghe","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c348","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jtcvs.2012.05.043","article-title":"Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris","volume":"145","author":"Fukui","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080919270629000_c349","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/bja\/aew189","article-title":"Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study","volume":"117","author":"Malm","year":"2016","journal-title":"Br J Anaesth"},{"key":"2026080919270629000_c350","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjcard.2017.04.038","article-title":"Comparison of outcome of coronary artery bypass grafting versus drug-eluting stent implantation for non-ST-elevation acute coronary syndrome","volume":"120","author":"Chang","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c351","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.jacc.2017.10.029","article-title":"Surgical versus percutaneous coronary revascularization in patients with diabetes and acute coronary syndromes","volume":"70","author":"Ramanathan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c352","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c353","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"2026080919270629000_c354","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"2026080919270629000_c355","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jacc.2011.02.032","article-title":"Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial","volume":"57","author":"Palmerini","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c356","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ejcts\/ezu033","article-title":"Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation","volume":"46","author":"Osnabrugge","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026080919270629000_c357","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/CIRCULATIONAHA.117.029779","article-title":"Timing of angiography and outcomes in high-risk patients with non-ST-segment-elevation myocardial infarction managed invasively: insights from the TAO trial (Treatment of Acute Coronary Syndrome With Otamixaban)","volume":"136","author":"Deharo","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c358","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa1816897","article-title":"Coronary angiography after cardiac arrest without ST-segment elevation","volume":"380","author":"Lemkes","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c359","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2018.12.005","article-title":"Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation: design and rationale of the TOMAHAWK trial","volume":"209","author":"Desch","year":"2019","journal-title":"Am Heart J"},{"key":"2026080919270629000_c360","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c361","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c362","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.jcin.2019.07.018","article-title":"1-year outcomes of delayed versus immediate intervention in patients with transient ST-segment elevation myocardial infarction","volume":"12","author":"Janssens","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c363","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c364","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4244\/EIJV10I1A7","article-title":"European Association for Percutaneous Cardiovascular Interventions (EAPCI), Stent for Life (SFL) Group. Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)\/stent for life (SFL) groups","volume":"10","author":"Noc","year":"2014","journal-title":"EuroIntervention"},{"key":"2026080919270629000_c365","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"2026080919270629000_c366","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/eurheartj\/ehv203","article-title":"Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c367","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archinte.1939.00190020035003","article-title":"Myocardial infarction without significant lesions of coronary arteries","volume":"64","author":"Gross","year":"1939","journal-title":"Arch Intern Med (Chic)"},{"key":"2026080919270629000_c368","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archinte.166.13.1391","article-title":"Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography","volume":"166","author":"Bugiardini","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026080919270629000_c369","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Joint tWGobot, Myocardial EAAWTFftUDo, Infarction. Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c370","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.117.027666","article-title":"Myocardial infarction with nonobstructive coronary arteries (MINOCA): the past, present, and future management","volume":"135","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c371","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004185","article-title":"Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: a meta-analysis","volume":"5","author":"Pizzi","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026080919270629000_c372","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009174","article-title":"\u00a0Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study","volume":"7","author":"Safdar","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026080919270629000_c373","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2018.03.092","article-title":"Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA)","volume":"267","author":"Ciliberti","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c374","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijcard.2018.04.004","article-title":"Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study","volume":"264","author":"Bainey","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c375","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCINTERVENTIONS.113.000606","article-title":"Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial","volume":"7","author":"Planer","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080919270629000_c376","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijcard.2009.07.001","article-title":"Korea Acute Myocardial Infarction Registry Investigators. Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe?","volume":"146","author":"Kang","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c377","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/eurheartj\/ehx491","article-title":"Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease","volume":"39","author":"Andersson","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c378","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ehjqcco\/qcv014","article-title":"Angina frequency after acute myocardial infarction in patients without obstructive coronary artery disease","volume":"1","author":"Grodzinsky","year":"2015","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026080919270629000_c379","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2004.09.014","article-title":"Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries","volume":"95","author":"Larsen","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c380","first-page":"143","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c381","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Council on Quality of Care and Outcomes Research. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"2026080919270629000_c382","first-page":"171","article-title":"Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome?","volume":"11","author":"Redfors","year":"2014","journal-title":"J Geriatr Cardiol"},{"key":"2026080919270629000_c383","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ejhf.424","article-title":"Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology","volume":"18","author":"Lyon","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026080919270629000_c384","first-page":"277","article-title":"Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy","volume":"306","author":"Eitel","year":"2011","journal-title":"JAMA"},{"key":"2026080919270629000_c385","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c386","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.jacc.2016.02.013","article-title":"comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-Trial","volume":"67","author":"Lurz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c387","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1093\/eurheartj\/ehn433","article-title":"Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging","volume":"29","author":"Eitel","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c388","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ehjci\/jev289","article-title":"Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging","volume":"17","author":"Pathik","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080919270629000_c389","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2015.04.816","article-title":"Myocarditis or \"true\" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: a meta-analysis of individual patient data","volume":"241","author":"Tornvall","year":"2015","journal-title":"Atherosclerosis"},{"key":"2026080919270629000_c390","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2017.05.109","article-title":"Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm","volume":"244","author":"Ciliberti","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c391","first-page":"91","article-title":"Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests","volume":"39","author":"Montone","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c392","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2007.04.082","article-title":"Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy","volume":"50","author":"Kubo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c393","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcmg.2012.12.012","article-title":"A \"stable\" coronary plaque rupture documented by repeated OCT studies","volume":"6","author":"Di Vito","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080919270629000_c394","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijcard.2016.08.026","article-title":"Optical coherence tomography-based diagnosis in a patient with ST-elevation myocardial infarction and no obstructive coronary arteries","volume":"223","author":"Takahashi","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c395","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10554-011-9879-1","article-title":"Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries","volume":"28","author":"Gerbaud","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026080919270629000_c396","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.jacc.2017.09.034","article-title":"A short history of vasospastic angina","volume":"70","author":"Bugiardini","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c397","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"2026080919270629000_c398","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ejhf.682","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","volume":"19","author":"Arrigo","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026080919270629000_c399","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jchf.2013.02.007","article-title":"Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes","volume":"1","author":"Bahit","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026080919270629000_c400","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Failure Long-Term Registry Investigators. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026080919270629000_c401","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Global Registry of Acute Coronary Events Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"2026080919270629000_c402","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1831","article-title":"Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology","author":"Harjola","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026080919270629000_c403","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ejhf.289","article-title":"Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine","volume":"17","author":"Mebazaa","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080919270629000_c404","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026080919270629000_c405","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c406","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.100.20.2067","article-title":"Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation","volume":"100","author":"Holmes","year":"1999","journal-title":"Circulation"},{"key":"2026080919270629000_c407","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2015.10.006","article-title":"Trends in coronary angiography, revascularization, and outcomes of cardiogenic shock complicating non-ST-elevation myocardial infarction","volume":"117","author":"Kolte","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c408","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c409","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","article-title":"Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials","volume":"38","author":"Thiele","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c410","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","article-title":"Impella support for acute myocardial infarction complicated by cardiogenic shock","volume":"139","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"2026080919270629000_c411","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","article-title":"The evolving landscape of impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support","volume":"141","author":"Amin","year":"2020","journal-title":"Circulation"},{"key":"2026080919270629000_c412","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"key":"2026080919270629000_c413","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c414","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"2026080919270629000_c415","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.118.038201","article-title":"IABPSHOCK II Trial (Intraaortic Balloon Pump in Cardiogenic Shock II) Investigators. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial","author":"Thiele","year":"2019","journal-title":"Circulation"},{"key":"2026080919270629000_c416","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"2026080919270629000_c417","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c418","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2003.08.050","article-title":"Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization","volume":"43","author":"Norhammar","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c419","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jech-2016-207402","article-title":"Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study","volume":"71","author":"Alabas","year":"2017","journal-title":"J Epidemiol Community Health"},{"key":"2026080919270629000_c420","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"2026080919270629000_c421","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","article-title":"PLATO Study Group. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"31","author":"James","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c422","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Study Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c423","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1093\/eurheartj\/ehl220","article-title":"Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c424","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/eurheartj\/eht332","article-title":"Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial","volume":"34","author":"Mellbin","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c425","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2337\/dc14-1329","article-title":"Predictors of nonsevere and severe hypoglycemia during glucose-lowering treatment with insulin glargine or standard drugs in the ORIGIN trial","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"2026080919270629000_c426","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.beem.2016.06.004","article-title":"Managing hypoglycaemia","volume":"30","author":"Iqbal","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026080919270629000_c427","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00125-017-4422-0","article-title":"DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality","volume":"61","author":"Pieber","year":"2018","journal-title":"Diabetologia"},{"key":"2026080919270629000_c428","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.314.7093.1512","article-title":"Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group","volume":"314","author":"Malmberg","year":"1997","journal-title":"BMJ"},{"key":"2026080919270629000_c429","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c430","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-8587(14)70088-9","article-title":"Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial","volume":"2","author":"Ritsinger","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080919270629000_c431","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/01.hjr.0000277984.31558.c4","article-title":"European Society of Cardiology (ESC), European Association for Cardiovascular Prevention and Rehabilitation (EACPR), Council on Cardiovascular Nursing, European Association for Study of Diabetes (EASD), International Diabetes Federation Europe (IDF-Europe), European Stroke Initiative (EUSI), International Society of Behavioural Medicine (ISBM), European Society of Hypertension (ESH), European Society of General Practice\/Family Medicine (ESGP\/FM\/WONCA), European Heart Network (EHN). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)","volume":"14 Suppl 2","author":"Graham","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2026080919270629000_c432","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c433","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-015-0296-y","article-title":"Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology","volume":"14","author":"Gyberg","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"2026080919270629000_c434","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","article-title":"Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial","volume":"5","author":"Ueki","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080919270629000_c435","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00125-018-4642-y","article-title":"Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study","volume":"61","author":"Oellgaard","year":"2018","journal-title":"Diabetologia"},{"key":"2026080919270629000_c436","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c437","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c438","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register","volume":"268","author":"Szummer","year":"2010","journal-title":"J Intern Med"},{"key":"2026080919270629000_c439","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/CIRCULATIONAHA.114.014245","article-title":"Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction","volume":"131","author":"Twerenbold","year":"2015","journal-title":"Circulation"},{"key":"2026080919270629000_c440","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","article-title":"Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"2026080919270629000_c441","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jama.300.9.1038","article-title":"Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial","volume":"300","author":"Brar","year":"2008","journal-title":"JAMA"},{"key":"2026080919270629000_c442","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004383","article-title":"\u00a0Preventive strategies for contrast-induced acute kidney injury in patients undergoing percutaneous coronary procedures: evidence from a hierarchical bayesian network meta-analysis of 124 trials and 28 240 patients","volume":"10","author":"Giacoppo","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080919270629000_c443","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"2026080919270629000_c444","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"key":"2026080919270629000_c445","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","article-title":"Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial","volume":"389","author":"Nijssen","year":"2017","journal-title":"Lancet"},{"key":"2026080919270629000_c446","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"PRESERVE Trial Group. Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c447","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","article-title":"Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"122","author":"James","year":"2010","journal-title":"Circulation"},{"key":"2026080919270629000_c448","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet"},{"key":"2026080919270629000_c449","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1681\/ASN.2012060554","article-title":"Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD","volume":"23","author":"Chang","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2026080919270629000_c450","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ejcts\/ezs360","article-title":"Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention in patients with end-stage renal disease","volume":"43","author":"Zheng","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026080919270629000_c451","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amjcard.2011.09.046","article-title":"Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes","volume":"109","author":"Younge","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c452","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/eurheartj\/ehp401","article-title":"OASIS 5 and OASIS 6 Investigators. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes","volume":"31","author":"Bassand","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c453","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/hrt.2007.136390","article-title":"Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)","volume":"94","author":"Chase","year":"2008","journal-title":"Heart"},{"key":"2026080919270629000_c454","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jacc.2004.04.034","article-title":"Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials","volume":"44","author":"Agostoni","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c455","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcin.2015.11.015","article-title":"Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention?: a pre-specified analysis from the ZEUS trial","volume":"9","author":"Ariotti","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c456","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1378\/chest.126.2.461","article-title":"Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events","volume":"126","author":"Brieger","year":"2004","journal-title":"Chest"},{"key":"2026080919270629000_c457","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehi774","article-title":"Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey","volume":"27","author":"Rosengren","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c458","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/eurheartj\/ehr033","article-title":"Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays","volume":"32","author":"Reiter","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c459","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1161\/CIRCULATIONAHA.111.025452","article-title":"Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction","volume":"124","author":"Ekerstad","year":"2011","journal-title":"Circulation"},{"key":"2026080919270629000_c460","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty assessment in the cardiovascular care of older adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c461","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/CIRCULATIONAHA.107.182615","article-title":"American Heart Association Council on Clinical Cardiology, Society of Geriatric Cardiology. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on clinical cardiology: in collaboration with the Society of Geriatric Cardiology","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation"},{"key":"2026080919270629000_c462","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehm464","article-title":"Acute Coronary Syndromes Registry (ACOS) Investigators. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction","volume":"28","author":"Bauer","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c463","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-141-3-200408030-00007","article-title":"The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes","volume":"141","author":"Bach","year":"2004","journal-title":"Ann Intern Med"},{"key":"2026080919270629000_c464","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(15)01166-6","article-title":"After Eighty study investigators. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial","volume":"387","author":"Tegn","year":"2016","journal-title":"Lancet"},{"key":"2026080919270629000_c465","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2007.01.066","article-title":"Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative","volume":"49","author":"Skolnick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c466","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2019.2306","article-title":"Effect of simvastatin-ezetimibe compared with simvastatin monotherapy after acute coronary syndrome among patients 75 years or older: a secondary analysis of a randomized clinical trial","author":"Bach","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026080919270629000_c467","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/heartjnl-2011-300453","article-title":"Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials","volume":"98","author":"Damman","year":"2012","journal-title":"Heart"},{"key":"2026080919270629000_c468","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/cc9297","article-title":"Frailty in the critically ill: a novel concept","volume":"15","author":"McDermid","year":"2011","journal-title":"Crit Care"},{"key":"2026080919270629000_c469","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"2026080919270629000_c470","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cger.2016.01.013","article-title":"Epidemiology of multimorbidity in older adults with cardiovascular disease","volume":"32","author":"Bell","year":"2016","journal-title":"Clin Geriatr Med"},{"key":"2026080919270629000_c471","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCOUTCOMES.111.961375","article-title":"Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization","volume":"4","author":"Singh","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080919270629000_c472","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.4244\/EIJ-D-18-00848","article-title":"Coronary artery lesion phenotype in frail older patients with non-ST-elevation acute coronary syndrome undergoing invasive care","volume":"15","author":"Gu","year":"2019","journal-title":"EuroIntervention"},{"key":"2026080919270629000_c473","first-page":"231","article-title":"Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial","volume":"5","author":"White","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c474","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijcard.2018.09.086","article-title":"ICON-1 Study Investigators. One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: an analysis of the ICON1 study","volume":"274","author":"Batty","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c475","first-page":"166","article-title":"Frailty and acute coronary syndrome: a structured literature review","volume":"7","author":"Bebb","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c476","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.arr.2010.09.001","article-title":"Olde Rikkert MG, Nijhuis-van der Sanden MW. Outcome instruments to measure frailty: a systematic review","volume":"10","author":"de Vries","year":"2011","journal-title":"Ageing Res Rev"},{"key":"2026080919270629000_c477","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jcin.2016.05.046","article-title":"Impact of sex on 2-year clinical outcomes in patients treated with 6-month or 24-month dual-antiplatelet therapy duration: a pre-specified analysis from the PRODIGY trial","volume":"9","author":"Gargiulo","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919270629000_c478","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007123","article-title":"Sex differences \u00a0in treatments, relative survival, and excess mortality following acute myocardial infarction: national cohort study using the SWEDEHEART Registry","volume":"6","author":"Alabas","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026080919270629000_c479","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ahj.2017.06.014","article-title":"Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes","volume":"191","author":"Gudnadottir","year":"2017","journal-title":"Am Heart J"},{"key":"2026080919270629000_c480","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13049","article-title":"Sex-related inequalities in management of patients with acute coronary syndrome-results from the EURHOBOP study","volume":"72","author":"Araujo","year":"2018","journal-title":"Int J Clin Pract"},{"key":"2026080919270629000_c481","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajem.2018.05.005","article-title":"Gender-based outcome differences for emergency department presentation ofnon-STEMI acute coronary syndrome","volume":"37","author":"Langabeer","year":"2019","journal-title":"Am J Emerg Med"},{"key":"2026080919270629000_c482","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41598-018-36504-y","article-title":"Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S","volume":"9","author":"Rashid","year":"2019","journal-title":"Sci Rep"},{"key":"2026080919270629000_c483","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heartjnl-2018-313959","article-title":"Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study","volume":"105","author":"Wilkinson","year":"2019","journal-title":"Heart"},{"key":"2026080919270629000_c484","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/CIR.0000000000000061","article-title":"American Heart Association Cardiac Imaging Committee of the Council on Clinical Cardiology, Cardiovascular Imaging and Intervention Committee of the Council on Cardiovascular Radiology and Intervention. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association","volume":"130","author":"Mieres","year":"2014","journal-title":"Circulation"},{"key":"2026080919270629000_c485","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"2026080919270629000_c486","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c487","first-page":"CD001800","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease","author":"Anderson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919270629000_c488","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.amjcard.2014.03.033","article-title":"Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study)","volume":"113","author":"Booth","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c489","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1177\/2047487318795194","article-title":"Associations of leisure-time physical activity with cardiovascular mortality: A systematic review and meta-analysis of 44 prospective cohort studies","volume":"25","author":"Cheng","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2026080919270629000_c490","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow","year":"2010","journal-title":"Circulation"},{"key":"2026080919270629000_c491","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA"},{"key":"2026080919270629000_c492","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1001\/archinte.168.20.2194","article-title":"Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network","volume":"168","author":"Giannuzzi","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026080919270629000_c493","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2008.03.017","article-title":"Peak aerobic capacity predicts prognosis in patients with coronary heart disease","volume":"156","author":"Keteyian","year":"2008","journal-title":"Am Heart J"},{"key":"2026080919270629000_c494","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2017.10.002","article-title":"Effect of changes in physical activity on risk for cardiac death in patients with coronary artery disease","volume":"121","author":"Lahtinen","year":"2018","journal-title":"Am J Cardiol"},{"key":"2026080919270629000_c495","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijcard.2016.11.059","article-title":"EuroCaReD study group. Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry","volume":"228","author":"Benzer","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c496","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jacc.2017.08.017","article-title":"Physical activity and mortality in patients with stable coronary heart disease","volume":"70","author":"Stewart","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c497","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/eurheartj\/ehv111","article-title":"Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients","volume":"36","author":"de Vries","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c498","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/HCR.0b013e318220a7c9","article-title":"Psychoeducational rehabilitation for health behavior change in coronary artery disease: a systematic review of controlled trials","volume":"31","author":"Aldcroft","year":"2011","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2026080919270629000_c499","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIR.0b013e3181e8edf1","article-title":"American Heart Association Prevention Committee of the Council on Cardiovascular Nursing. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association","volume":"122","author":"Artinian","year":"2010","journal-title":"Circulation"},{"key":"2026080919270629000_c500","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/2047487312462824","article-title":"Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Janssen","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"2026080919270629000_c501","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1177\/2047487316671181","article-title":"\u2018Cardiac Rehabilitation Section\u2019, European Association of Preventive Cardiology (EAPC), in cooperation with the Institute of Medical Biometry and Informatics (IMBI), Department of Medical Biometry, University of Heidelberg, and the Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Heinrich-Heine University, D\u00fcsseldorf, Germany. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS)","volume":"23","author":"Rauch","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026080919270629000_c502","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3399\/bjgp10X482095","article-title":"Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial","volume":"60","author":"Voogdt-Pruis","year":"2010","journal-title":"Br J Gen Pract"},{"key":"2026080919270629000_c503","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0140-6736(08)60868-5","article-title":"EUROACTION Study Group. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial","volume":"371","author":"Wood","year":"2008","journal-title":"Lancet"},{"key":"2026080919270629000_c504","first-page":"CD006886","article-title":"Psychosocial interventions for smoking cessation in patients with coronary heart disease","author":"Barth","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919270629000_c505","first-page":"CD008012","article-title":"Psychological and pharmacological interventions for depression in patients with coronary artery disease","author":"Baumeister","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919270629000_c506","doi-asserted-by":"crossref","first-page":"424","DOI":"10.20344\/amp.6846","article-title":"[Analysis of the Cochrane Review: influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5:CD005050]","volume":"28","author":"Caldeira","year":"2015","journal-title":"Acta Med Port"},{"key":"2026080919270629000_c507","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0140-6736(18)30143-0","article-title":"Influenza vaccination and prevention of cardiovascular disease mortality","volume":"391","author":"Caldeira","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c508","first-page":"CD005050","article-title":"Influenza vaccines for preventing cardiovascular disease","author":"Clar","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919270629000_c509","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1136\/heartjnl-2016-309983","article-title":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction","volume":"102","author":"MacIntyre","year":"2016","journal-title":"Heart"},{"key":"2026080919270629000_c510","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/14779072.2015.1044439","article-title":"Does influenza vaccination influence cardiovascular complications?","volume":"13","author":"Udell","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026080919270629000_c511","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(18)30144-2","article-title":"Influenza vaccination and prevention of cardiovascular disease mortality - authors' reply","volume":"391","author":"Paules","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c512","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2026080919270629000_c513","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","article-title":"IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators. Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)","volume":"137","author":"Giugliano","year":"2018","journal-title":"Circulation"},{"key":"2026080919270629000_c514","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c515","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2017.07.745","article-title":"2017 focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways","volume":"70","author":"Lloyd-Jones","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c516","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2017.07.752","article-title":"Optimizing cholesterol treatment in patients with muscle complaints","volume":"70","author":"Rosenson","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c517","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/humrep\/dex377","article-title":"In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization","volume":"33","author":"Silvestris","year":"2018","journal-title":"Hum Reprod"},{"key":"2026080919270629000_c518","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.116.024604","article-title":"Reductions in atherogenic lipids and major cardiovascular events: a pooled analysis of 10 ODYSSEY trials comparing alirocumab with control","volume":"134","author":"Ray","year":"2016","journal-title":"Circulation"},{"key":"2026080919270629000_c519","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c520","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c521","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S2213-8587(19)30158-5","article-title":"ODYSSEY OUTCOMES Committees and Investigators. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","volume":"7","author":"Ray","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080919270629000_c522","first-page":"CD011748","article-title":"PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease","volume":"4","author":"Schmidt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919270629000_c523","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jacc.2016.11.037","article-title":"Safety of very low low-density lipoprotein cholesterol levels with alirocumab: pooled data from randomized trials","volume":"69","author":"Robinson","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c524","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijcard.2016.06.126","article-title":"PCSK9 inhibitors may improve cardiovascular outcomes-can we afford them?","volume":"220","author":"Arbel","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080919270629000_c525","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/clc.22471","article-title":"Effect of high-dose statin pretreatment on the incidence of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: grading the evidence through a cumulative meta-analysis","volume":"38","author":"Zhai","year":"2015","journal-title":"Clin Cardiol"},{"key":"2026080919270629000_c526","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c527","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Harmony Outcomes committees and investigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"2026080919270629000_c528","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"SUSTAIN-6 Investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c529","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"LEADER Steering Committee, LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c530","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"CANVAS Program Collaborative Group. Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c531","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c532","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c533","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"2026080919270629000_c534","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"2026080919270629000_c535","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c536","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"2026080919270629000_c537","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c538","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c539","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1067\/mhj.2002.120768","article-title":"Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies\u2013CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study","volume":"143","author":"Leizorovicz","year":"2002","journal-title":"Am Heart J"},{"key":"2026080919270629000_c540","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c541","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"2026080919270629000_c542","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1253\/circj.CJ-18-0662","article-title":"Prognostic impact of beta-blocker dose after acute myocardial infarction","volume":"83","author":"Hwang","year":"2019","journal-title":"Circ J"},{"key":"2026080919270629000_c543","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","article-title":"Beta-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080919270629000_c544","doi-asserted-by":"crossref","first-page":"i4801","DOI":"10.1136\/bmj.i4801","article-title":"Beta blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study","volume":"354","author":"Puymirat","year":"2016","journal-title":"BMJ"},{"key":"2026080919270629000_c545","doi-asserted-by":"crossref","first-page":"e004356","DOI":"10.1161\/CIRCOUTCOMES.117.004356","article-title":"Clinical events after discontinuation of beta-blockers in patients without heart failure optimally treated after acute myocardial infarction: a cohort study on the French healthcare databases","volume":"11","author":"Neumann","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080919270629000_c546","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jacc.2003.09.071","article-title":"Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?","volume":"43","author":"Kernis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c547","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"2026080919270629000_c548","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c549","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c550","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/01.CIR.0000157096.95223.D7","article-title":"American Heart Association Task Force on Performance Measures. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care","volume":"111","author":"Spertus","year":"2005","journal-title":"Circulation"},{"key":"2026080919270629000_c551"},{"key":"2026080919270629000_c552","author":"Raleigh","year":"2020"},{"key":"2026080919270629000_c553","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJMsa064964","article-title":"Public reporting and pay for performance in hospital quality improvement","volume":"356","author":"Lindenauer","year":"2007","journal-title":"N Engl J Med"},{"key":"2026080919270629000_c554","first-page":"e75","article-title":"The use of quality indicators to promote accountability in health care: the good, the bad, and the ugly","volume":"6","author":"Forster","year":"2012","journal-title":"Open Med"},{"key":"2026080919270629000_c555","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.jacc.2015.07.010","article-title":"ACC\/AHA\/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons","volume":"66","author":"Bhatt","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c556","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1988.03410120089033","article-title":"The quality of care. How can it be assessed?","volume":"260","author":"Donabedian","year":"1988","journal-title":"JAMA"},{"key":"2026080919270629000_c557","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.jacc.2010.09.009","article-title":"ACCF\/AHA Task Force on Performance Measures. ACCF\/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on performance measures","volume":"56","author":"Spertus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919270629000_c558","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1377\/hlthaff.26.1.75","article-title":"Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement","volume":"26","author":"Krumholz","year":"2007","journal-title":"Health Aff (Millwood)"},{"key":"2026080919270629000_c559","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/CIRCOUTCOMES.116.002781","article-title":"Predictors of physician under-recognition of angina in outpatients with stable coronary artery disease","volume":"9","author":"Arnold","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080919270629000_c560","first-page":"34","article-title":"Quality indicators for acute myocardial infarction: a position paper of the Acute Cardiovascular Care Association","volume":"6","author":"Schiele","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080919270629000_c561","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003336","article-title":"Assessment of quality indicators for acute myocardial infarction in the FAST-MI (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) Registries","volume":"10","author":"Schiele","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080919270629000_c562","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/jep.12881","article-title":"Assessment of quality performance measures in patients with acute coronary syndromes: data from the Portuguese Registry of Acute Coronary Syndromes (ProACS), a nationwide registry","volume":"24","author":"Timoteo","year":"2018","journal-title":"J Eval Clin Pract"},{"key":"2026080919270629000_c563","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/eurheartj\/ehx008","article-title":"Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register","volume":"38","author":"Bebb","year":"2017","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/14\/1289\/41217030\/ehaa575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/14\/1289\/41217030\/ehaa575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:28:21Z","timestamp":1786318101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/14\/1289\/5898842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":563,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,8,29]]},"published-print":{"date-parts":[[2021,4,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738577347.793583468","asserted-by":"object"}]},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,7]]},"published":{"date-parts":[[2020,8,29]]}}}